Literature DB >> 23445662

Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management.

Celia L Gregson1, Sarah A Hardcastle, Cyrus Cooper, Jonathan H Tobias.   

Abstract

A finding of high BMD on routine DXA scanning is not infrequent and most commonly reflects degenerative disease. However, BMD increases may also arise secondary to a range of underlying disorders affecting the skeleton. Although low BMD increases fracture risk, the converse may not hold for high BMD, since elevated BMD may occur in conditions where fracture risk is increased, unaffected or reduced. Here we outline a classification for the causes of raised BMD, based on identification of focal or generalized BMD changes, and discuss an approach to guide appropriate investigation by clinicians after careful interpretation of DXA scan findings within the context of the clinical history. We will also review the mild skeletal dysplasia associated with the currently unexplained high bone mass phenotype and discuss recent advances in osteoporosis therapies arising from improved understanding of rare inherited high BMD disorders.

Entities:  

Keywords:  BMD; DXA; high bone mass; osteoarthritis; osteopetrosis

Mesh:

Year:  2013        PMID: 23445662      PMCID: PMC3651616          DOI: 10.1093/rheumatology/ket007

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  188 in total

1.  Hepatitis C-associated osteosclerosis after blood transfusion.

Authors:  M P Whyte; C A Reasner
Journal:  Am J Med       Date:  1997-02       Impact factor: 4.965

Review 2.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1994

Review 3.  Osteochondral alterations in osteoarthritis.

Authors:  Sunita Suri; David A Walsh
Journal:  Bone       Date:  2011-10-17       Impact factor: 4.398

4.  Molecular and clinical heterogeneity in CLCN7-dependent osteopetrosis: report of 20 novel mutations.

Authors:  Alessandra Pangrazio; Michael Pusch; Elena Caldana; Annalisa Frattini; Edoardo Lanino; Parag M Tamhankar; Shubha Phadke; Antonio Gonzalez Meneses Lopez; Paul Orchard; Ercan Mihci; Mario Abinun; Michael Wright; Kim Vettenranta; Ivo Bariae; Daniela Melis; Ilhan Tezcan; Clarisse Baumann; Franco Locatelli; Marco Zecca; Edwin Horwitz; Lamia Sfaihi Ben Mansour; Mirjam Van Roij; Paolo Vezzoni; Anna Villa; Cristina Sobacchi
Journal:  Hum Mutat       Date:  2010-01       Impact factor: 4.878

Review 5.  Pycnodysostosis. Report of a case and review of the Japanese literature, with emphasis on oral and maxillofacial findings.

Authors:  T Muto; H Michiya; H Taira; H Murase; M Kanazawa
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1991-10

6.  Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis.

Authors:  S Donnelly; D V Doyle; A Denton; I Rolfe; E V McCloskey; T D Spector
Journal:  Ann Rheum Dis       Date:  1994-02       Impact factor: 19.103

7.  Hepatitis C-associated osteosclerosis: a case report.

Authors:  Kara M Schwartz; John A Skinner
Journal:  Skeletal Radiol       Date:  2008-04-15       Impact factor: 2.199

8.  A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population.

Authors:  Karen Staehling-Hampton; Sean Proll; Bryan W Paeper; Lei Zhao; Patrick Charmley; Analisa Brown; Jessica C Gardner; David Galas; Randall C Schatzman; Peter Beighton; Socrates Papapoulos; Herman Hamersma; Mary E Brunkow
Journal:  Am J Med Genet       Date:  2002-06-15

9.  Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk.

Authors:  Emma L Duncan; Patrick Danoy; John P Kemp; Paul J Leo; Eugene McCloskey; Geoffrey C Nicholson; Richard Eastell; Richard L Prince; John A Eisman; Graeme Jones; Philip N Sambrook; Ian R Reid; Elaine M Dennison; John Wark; J Brent Richards; Andre G Uitterlinden; Tim D Spector; Chris Esapa; Roger D Cox; Steve D M Brown; Rajesh V Thakker; Kathryn A Addison; Linda A Bradbury; Jacqueline R Center; Cyrus Cooper; Catherine Cremin; Karol Estrada; Dieter Felsenberg; Claus-C Glüer; Johanna Hadler; Margaret J Henry; Albert Hofman; Mark A Kotowicz; Joanna Makovey; Sing C Nguyen; Tuan V Nguyen; Julie A Pasco; Karena Pryce; David M Reid; Fernando Rivadeneira; Christian Roux; Kari Stefansson; Unnur Styrkarsdottir; Gudmar Thorleifsson; Rumbidzai Tichawangana; David M Evans; Matthew A Brown
Journal:  PLoS Genet       Date:  2011-04-21       Impact factor: 5.917

10.  The high bone mass phenotype is characterised by a combined cortical and trabecular bone phenotype: findings from a pQCT case-control study.

Authors:  Celia L Gregson; Adrian Sayers; Victor Lazar; Sue Steel; Elaine M Dennison; Cyrus Cooper; George Davey Smith; Jörn Rittweger; Jon H Tobias
Journal:  Bone       Date:  2012-10-24       Impact factor: 4.398

View more
  24 in total

1.  Bone geometry, bone mineral density, and micro-architecture in patients with myelofibrosis: a cross-sectional study using DXA, HR-pQCT, and bone turnover markers.

Authors:  Sarah Farmer; Hanne Vestergaard; Stinus Hansen; Vikram Vinod Shanbhogue; Vikram Vinod Shanbhoque; Claudia Irene Stahlberg; Anne Pernille Hermann; Henrik Frederiksen
Journal:  Int J Hematol       Date:  2015-05-05       Impact factor: 2.490

2.  Local bone quality measurements correlates with maximum screw torque at the femoral diaphysis.

Authors:  Christopher M McAndrew; Avinesh Agarwalla; Adam C Abraham; Eric Feuchtbaum; William M Ricci; Simon Y Tang
Journal:  Clin Biomech (Bristol, Avon)       Date:  2018-02-03       Impact factor: 2.063

3.  Multiscale Predictors of Femoral Neck In Situ Strength in Aging Women: Contributions of BMD, Cortical Porosity, Reference Point Indentation, and Nonenzymatic Glycation.

Authors:  Adam C Abraham; Avinesh Agarwalla; Aditya Yadavalli; Christopher McAndrew; Jenny Y Liu; Simon Y Tang
Journal:  J Bone Miner Res       Date:  2015-07-14       Impact factor: 6.741

4.  Rapid skeletal turnover in a radiographic mimic of osteopetrosis.

Authors:  Michael P Whyte; Katherine L Madson; Steven Mumm; William H McAlister; Deborah V Novack; Jo C Blair; Timothy R Helliwell; Marina Stolina; Laurence J Abernethy; Nicholas J Shaw
Journal:  J Bone Miner Res       Date:  2014-12       Impact factor: 6.741

5.  Hormone therapy and osteoporosis in breast cancer survivors: assessment of risk and adherence to screening recommendations.

Authors:  R Hamood; H Hamood; I Merhasin; L Keinan-Boker
Journal:  Osteoporos Int       Date:  2018-11-09       Impact factor: 4.507

6.  Computer-Aided Detection of Incidental Lumbar Spine Fractures from Routine Dual-Energy X-Ray Absorptiometry (DEXA) Studies Using a Support Vector Machine (SVM) Classifier.

Authors:  Samir D Mehta; Ronnie Sebro
Journal:  J Digit Imaging       Date:  2020-02       Impact factor: 4.056

Review 7.  MANAGEMENT OF ENDOCRINE DISEASE: Bone complications of bariatric surgery: updates on sleeve gastrectomy, fractures, and interventions.

Authors:  Kristen M Beavers; Katelyn A Greene; Elaine W Yu
Journal:  Eur J Endocrinol       Date:  2020-11       Impact factor: 6.664

8.  Idiopathic Acquired Osteosclerosis in a Middle-Aged Woman With Systemic Lupus Erythematosus.

Authors:  Núria Guañabens; Steven Mumm; Laia Gifre; Silvia Ruiz-Gaspà; Jennifer L Demertzis; Marina Stolina; Deborah V Novack; Michael P Whyte
Journal:  J Bone Miner Res       Date:  2016-05-09       Impact factor: 6.741

9.  Diffuse osteosclerosis in a patient with prostate cancer.

Authors:  N Ustün; I Ustün; T Ozgür; N Atci; F Aydoğan; A T Sümbül; A D Turhanoğlu
Journal:  Osteoporos Int       Date:  2013-10-18       Impact factor: 4.507

10.  Radiographic imaging, densitometry and disease severity in Autosomal dominant osteopetrosis type 2.

Authors:  Lauren M Ladd; Erik A Imel; Paul J Niziolek; Ziyue Liu; Stuart J Warden; Yun Liang; Michael J Econs
Journal:  Skeletal Radiol       Date:  2020-10-03       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.